Cases

2025 IL App (1st) 221581 No. 1-22-1581 Filed May 21, 2025 Third Division IN THE APPELLATE COURT OF ILLINOIS FIRST DISTRICT STEPHEN TWIGG, In

In the United States Court of Appeals For the Seventh Circuit ____________________ No. 24-3121 JEFFREY LEWIS, Plaintiff-Appellant, v. ABBVIE INC., f/k/a/ ALLERGAN, Defendant-Appellee. ____________________ Appeal from the United States District Court for the Nor

2021 IL App (1st) 200527 FIFTH DIVISION MARCH 31, 2021 No. 1-20-0527 CASTLERIGG MASTER INVESTMENTS, LTD., ) Appeal from the ) Circuit Court of Plaintiff-Appellant, ) Cook County.

2022 IL App (1st) 200872 FIFTH DIVISION FEBRUARY 4, 2022 No. 1-20-0872 QUAD CAPITAL PORTFOLIO A LLC, and ) Appeal from the QUAD SECURITIES PORTFOLIO A LLC, ) Circuit Court of ) Cook County. Plaintiffs-App

Digitally signed by Reporter of Decisions Reason: I attest to Illinois Official Reports the accuracy and

In the United States Court of Appeals For the Seventh Circuit ____________________ No. 19-3063 WALLEYE TRADING LLC, Plaintiff-Appellant, v. ABBVIE INC. and WILLIAM CHASE, Defendants-Appellees. ____________________ Appeal from the United States District Court for the

UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT Nos. 18-2621, 18-2748 & 18-2758 FEDERAL TRADE COMMISSION, Appellant in 18-2621 v. ABBVIE INC; ABBOT LABORATORIES; UNIMED PHARMACEUTICALS, LLC; BESINS HEALTHCARE, INC; *TEVA PHARMACEUTICALS USA INC AbbVie Inc; Abbott Laboratories; Unimed Pharmaceuticals, LLC,

PRECEDENTIAL UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT No. 18-2621 FEDERAL TRADE COMMISSION, Appellant v. ABBVIE INC.; ABBOTT LABORATORIES; UNIMED PHARMACEUTICALS, LLC; BESINS HEALTHCARE, INC.; *TEVA PHARMACEUTICALS USA, INC. (*Dismissed Pursuant to Court’s 3/12/19 Order.) No. 18-2748 FEDERAL TRADE COMMISSION

AFFIRMED.

In the United States Court of Appeals For the Seventh Circuit ____________________ No. 20-2402 MAYOR AND CITY COUNCIL OF BALTIMORE, et al., Plaintiffs-Appellants, v. ABBVIE INC., et al., Defendants-Appellees. ____________________ Appeal from the United States District C

United States Court of Appeals For the Seventh Circuit Chicago, Illinois 60604 August 2, 2022 Before FRANK H. EASTERBROOK, Circuit Judge DIANE P. WOOD, Circuit Judge THOMAS L. KIRSCH II, Circuit Judge No. 20-2402

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE SOUTHEASTERN PENNSYLVANIA ) TRANSPORTATION AUTHORITY, ) ) Plaintiff, ) ) v. ) C.A. No. 10374-VCG ) ABBVIE INC., ) ) Defendant.

ORDER RE MOTION TO REMANDJAMES DONATO, United States District Judge *1178This case was originally filed in Alameda Superior Court, and alleges a campaign of kickbacks and other inducements by defendant AbbVie Inc. to inflate sales of its Humira drug, which is used to treat autoimmune disorders such as arthritis and colitis. See

*1042MEMORANDUM OPINION AND ORDER MATTHEW F. KENNELLY, District Judge: Defendants AbbVie Inc. and Abbott Laboratories are pharmaceutical companies incorporated in Delaware, with their principal places of business in Illinois.1 Plaintiffs are ten unrelated individuals from nine different states (Missouri, Illi

PRECEDENTIAL UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT No. 18-2621 FEDERAL TRADE COMMISSION, Appellant v. ABBVIE INC; ABBOTT LABORATORIES; UNIMED PHARMACEUTICALS, LLC; BESINS HEALTHCARE, INC.; *TEVA PHARMACEUTICALS USA, INC (*Dismissed Pursuant to Court’s 3/12/19 Order.) No. 18-2748 FEDERAL TRADE COMMISSION,

In the United States Court of Appeals For the Seventh Circuit ____________________ No. 19-3063 WALLEYE TRADING LLC, Plaintiff-Appellant, v. ABBVIE INC. and WILLIAM CHASE, Defendants-Appellees. ____________________ Appeal from the United States District Court for the

To prevail in this antitrust litigation, the FTC must prove that defendants possessed monopoly power in the relevant market and that defendants willfully acquired or maintained that power. See Mylan Pharm. Inc. v. Warner Chilcott Pub. Ltd., 838 F.3d 421, 433 (3d Cir. 2016). Here, the FTC asserts that defendants maintained th

Quad Capital Portfolio A LLC v AbbVie Inc. (2022 NY Slip Op 00065) Quad Capital Portfolio A LLC v AbbVie Inc. 2022 NY Slip Op 00065 Decided on January 06, 2022 Appellate Division, First Department Published by New York

MEMORANDUM BARTLE, District Judge. The Federal Trade Commission (“FTC”) brings this action for injunctive and other equitable relief under § 5(a) of the Federal Trade Commission Act (“FTC Act”), 15 U.S.C. § 45(a), against defendants AbbVie, Inc. (“AbbVie”), Abbott Laboratories (“Abbott”), Unimed Pharmaceuticals, LLC (“Unimed” and, together with AbbVie and Abbott, the “AbbVie Defendants”)

*902MEMORANDUM OPINION AND ORDER (CORRECTED) MATTHEW F. KENNELLY, District Judge: Defendants in this MDL proceeding are manufacturers, sellers, and promoters of testosterone replacement therapy drugs (TRTs). Nearly all of the plaintiffs have brought lawsuits claiming personal injuries they claim were caused by TRTs. The Court has already ruled on a